Delays in Diabetes Diagnoses Seen for Children During Pandemic
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 16, 2024 -- For children, disruptions to care during the first 30 months of the pandemic were associated with delays in the diagnosis of diabetes, according to a study published online Jan. 16 in CMAJ, the journal of the Canadian Medical Association.
Carina Iskander, from ICES in Toronto, and colleagues conducted a repeated cross-sectional study of children aged 0 to 17 years to estimate changes in rates of severe and potentially preventable health outcomes during the pandemic.
The researchers observed a decrease in all acute care use for children immediately at the onset of the pandemic, reaching the lowest rate for emergency department visits and hospital admissions in April 2020 (adjusted relative rates, 0.28 and 0.43, respectively). These reductions were sustained until September 2021 and May 2022, respectively. Overall, the rates of all-cause mortality, admissions for ambulatory care-sensitive conditions, newborn readmissions or emergency department visits, or hospital admissions among children with chronic health conditions did not exceed predicted rates during the pandemic. New presentations of diabetes mellitus increased significantly during most of 2021 (peak adjusted relative rate, 1.49 in July 2021) and much of 2022 after declining significantly between March and May 2020. Among these children, significantly more presentations for diabetic ketoacidosis were seen during the pandemic overall compared with expected (adjusted relative rate, 1.14).
"Despite disruptions in access to primary care and changes in care-seeking behavior, we documented relatively few changes in measures of severe preventable harm across selected outcomes and populations, except delays in diagnosing new cases of diabetes," the authors write.
One author disclosed ties to Dexcom Canada.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Further Support and Information on COVID-19
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.